Skip to main content
Log in

PROs improve survival in metastatic cancer

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Basch E, et al. Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment. Journal of the American Medical Association : 4 Jun 2017. Available from: URL: http://dx.doi.org/10.1001/jama.2017.7156

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

PROs improve survival in metastatic cancer. PharmacoEcon Outcomes News 780, 29 (2017). https://doi.org/10.1007/s40274-017-4081-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-4081-x

Navigation